EMPLOYMENT AGREEMENTEmployment Agreement • March 1st, 2022 • Repare Therapeutics Inc. • Pharmaceutical preparations • Quebec
This Employment Agreement (the “Agreement”) is entered into as of June 12, 2020, by and between Steve Forte (the “Executive”) and Repare Therapeutics Inc. (the “Company”).
COMMENCEMENT DATE MEMORANDUMRepare Therapeutics Inc. • March 1st, 2022 • Pharmaceutical preparations
THIS MEMORANDUM, made as of February 25, 2021, by and between RREEF AMERICA REIT II CORP. PPP, a Maryland corporation (“Landlord”) and REPARE THERAPEUTICS USA, INC, a Delaware corporation (“Tenant”).
FIFTH (5TH) AMENDMENT TO LEASE AGREEMENT THIS FIFTH AMENDMENT TO LEASE AGREEMENT made this January-17-2022 BETWEEN: THE MANUFACTURERS LIFE INSURANCE COMPANY (hereinafter called the "Landlord") OF THE FIRST PART, AND REPARE THERAPEUTICS INC....Lease Agreement • March 1st, 2022 • Repare Therapeutics Inc. • Pharmaceutical preparations
WHEREAS pursuant to a Lease dated the 15th day of May, 2014 (the "Original Lease") between CIG III Technoparc Nominee Inc. (the "Prior Landlord") and Pharmascience Inc. (the "Prior Tenant"), as amended by a First Amendment to Lease Agreement dated the 24th day of November, 2016 (the "First Amendment"), the Prior Tenant leased certain premises located respectively on the ground floor of the building bearing civic address 7210 Frederick-Banting, in the City of Montreal (borough of Saint-Laurent), Province of Quebec (the "Building") comprising a Rentable Area of Nine Thousand Forty-Five (9,045) square feet and more particularly described in the Original Lease (the "Leased Premises"), for a term expiring on the 31st day of July, 2021 (the "Term"), unless otherwise terminated, the whole subject to and in accordance with the terms and conditions of the Lease;
